WHO ICTRP trial
Investigation of DNA medication passport for antidepressants in primary care.
NL-OMON27432 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON27432 |
|---|---|
| Public title | Investigation of DNA medication passport for antidepressants in primary care. |
| Scientific title | Investigation of DNA medication passport for antidepressants in primary care. |
| Primary sponsor | Erasmus University Medical Center, Dept. Clinical Chemistry Dr. Molewaterplein 40, 3015 GD Rotterdam |
| Secondary sponsors | Humo voor huisartsen, Wethouder van Eschstraat 50, 5342 AT Oss;BrabantFarmac ApothekersZorggroep, Mr. Goselingstraat 8 5481 BX Schijndel. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Conditions | mild to moderate depression and anxiety disorders ;10012375 |
| Interventions | farmacogenetica bepaling voor aanvang behandeling met antidepressivum ;Other intervention |
| Registration date | Jul 29, 2020 |
| Target size | 280 |
| Secondary IDs | NL8807;METC Erasmus MC : MEC-2019-0770 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: